社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
腾盛博药-B(02137)
1.450
-0.040
-2.68%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
腾盛博药-B
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.briibio.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran)，及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线，专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病（如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染）及其他疾病（如中枢神经系统(CNS)疾病）。该公司主要在中国国内市场开展业务。
09-18
半年度报告
2025 中期报告
2025 中期报告
08-27
年度报告
有关截至2024年12月31日止年度年报的补充公告
有关截至2024年12月31日止年度年报的补充公告
08-21
半年度报告
截至2025年6月30日止六个月之中期业绩公告
截至2025年6月30日止六个月之中期业绩公告
04-25
股份购回
(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告
(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告
04-25
年度报告
2024年度报告
2024年度报告
03-21
年度报告
截至2024年12月31日止年度之年度业绩公告及变更所得款项用途
截至2024年12月31日止年度之年度业绩公告及变更所得款项用途
01-10
须予披露的交易
补充公告有关代名人指派协议之须予披露交易
补充公告有关代名人指派协议之须予披露交易
2024-12-31
须予披露的交易
有关代名人指派协议之须予披露交易
有关代名人指派协议之须予披露交易
2024-09-19
半年度报告
2024 中期报告
2024 中期报告
2024-08-19
半年度报告
截至2024年6月30日止六个月之中期业绩公告
截至2024年6月30日止六个月之中期业绩公告
2024-04-25
股份购回
(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告
(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告
2024-04-25
年度报告
2023年度报告
2023年度报告
2024-03-22
年度报告
截至2023年12月31日止年度之年度业绩公告
截至2023年12月31日止年度之年度业绩公告
2024-02-14
须予披露的交易
有关BRII-179购买协议、技术转让补充协议、VBI-1901许可协议、REHOVOT资产购买协议及提供抵押之须予披露交易
有关BRII-179购买协议、技术转让补充协议、VBI-1901许可协议、REHOVOT资产购买协议及提供抵押之须予披露交易
2023-09-21
半年度报告
2023 中期报告
2023 中期报告
分时
5日
日
周
月
数据加载中...
最高
1.470
今开
1.470
量比
0.75
最低
1.450
昨收
1.490
换手率
0.07%
热议股票
{"pagemeta":{"title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"腾盛博药-B,02137,腾盛博药-B股票,腾盛博药-B股票老虎,腾盛博药-B股票老虎国际,腾盛博药-B行情,腾盛博药-B股票行情,腾盛博药-B股价,腾盛博药-B股市,腾盛博药-B股票价格,腾盛博药-B股票交易,腾盛博药-B股票购买,腾盛博药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"腾盛博药-B(02137)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供腾盛博药-B(02137)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"02137","data":{"stockData":{"symbol":"02137","market":"HK","secType":"STK","nameCN":"腾盛博药-B","latestPrice":1.45,"timestamp":1766549302725,"preClose":1.49,"halted":0,"volume":502863,"delay":0,"floatShares":721000000,"shares":721000000,"eps":-0.7718025558983764,"marketStatus":"休市中","change":-0.04,"latestTime":"12-24 12:08:22","open":1.47,"high":1.47,"low":1.45,"amount":733876,"amplitude":0.013423,"askPrice":1.46,"askSize":11500,"bidPrice":1.45,"bidSize":22500,"shortable":0,"etf":0,"ttmEps":-0.5730260513246963,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1626105600000,"exchange":"SEHK","adjPreClose":1.49,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.751765833173233,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"20181345","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6wo5h3swgd","pdf_url":"https://static.tigerbbs.com/ad3fe9420e67410787372a8542e95962","pub_time":1758184200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2025 中期报告","symbol":"02137","title":"2025 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0918/2025091800325_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-09-18 16:30","pubTimestamp":1758184200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20067183","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFiyjyG4ABq","pdf_url":"https://static.tigerbbs.com/a93726256ddd48a3bd3d8e78bf9f2b1f","pub_time":1756286340000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关截至2024年12月31日止年度年报的补充公告","symbol":"02137","title":"有关截至2024年12月31日止年度年报的补充公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0827/2025082700827_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 其他-杂项]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-08-27 17:19","pubTimestamp":1756286340,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20019500","market":"hk","labels":[],"media":"港交所","original_id":"N.HK2aLEPozhwQ","pdf_url":"https://static.tigerbbs.com/fdc1e02f72e94e7b9a64b236cafdc8f3","pub_time":1755770400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年6月30日止六个月之中期业绩公告","symbol":"02137","title":"截至2025年6月30日止六个月之中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0821/2025082100700_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2025-08-21 18:00","pubTimestamp":1755770400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19508405","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGMxktCXGpb","pdf_url":"https://static.tigerbbs.com/5a40c749cbf3474fa4eda2689326a001","pub_time":1745588160000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告","symbol":"02137","title":"(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042503492_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 在股东批准的情况下重选或委任董事]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-04-25 21:36","pubTimestamp":1745588160,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19508023","market":"hk","labels":[],"media":"港交所","original_id":"N.HK7n3Dn6YBSu","pdf_url":"https://static.tigerbbs.com/735c5c3a779f4439852f174fe3e03a35","pub_time":1745587620000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024年度报告","symbol":"02137","title":"2024年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0425/2025042503470_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-04-25 21:27","pubTimestamp":1745587620,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19268423","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGqkeqieMYX","pdf_url":"https://static.tigerbbs.com/4cb4072a8652488cb72ab132bb535a16","pub_time":1742555160000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年12月31日止年度之年度业绩公告及变更所得款项用途","symbol":"02137","title":"截至2024年12月31日止年度之年度业绩公告及变更所得款项用途","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0321/2025032101208_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 暂停办理过户登记手续或更改暂停办理过户日期 / 其他-业务发展最新情况]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-21 19:06","pubTimestamp":1742555160,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"19032199","market":"hk","labels":[],"media":"港交所","original_id":"N.HKFNyy59qe9b","pdf_url":"https://static.tigerbbs.com/2014ddb129bf4eefab5dc92dbdcecf3d","pub_time":1736506860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"补充公告有关代名人指派协议之须予披露交易","symbol":"02137","title":"补充公告有关代名人指派协议之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0110/2025011000992_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2025-01-10 19:01","pubTimestamp":1736506860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18998277","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4NKBCt52ep","pdf_url":"https://static.tigerbbs.com/0237e9015a714434ac192c90a5b63014","pub_time":1735642860000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关代名人指派协议之须予披露交易","symbol":"02137","title":"有关代名人指派协议之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/1231/2024123101811_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2024-12-31 19:01","pubTimestamp":1735642860,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18626552","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCyAmX8CiFh","pdf_url":"https://static.tigerbbs.com/de62d36db7184c15bc13c7ef2533ddec","pub_time":1726734840000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2024 中期报告","symbol":"02137","title":"2024 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0919/2024091900466_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-09-19 16:34","pubTimestamp":1726734840,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"18488390","market":"hk","labels":[],"media":"港交所","original_id":"N.HK4Q3NyYABcg","pdf_url":"https://static.tigerbbs.com/5ea0dbc83a2f4b2ba7c75c6da83123af","pub_time":1724067000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2024年6月30日止六个月之中期业绩公告","symbol":"02137","title":"截至2024年6月30日止六个月之中期业绩公告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0819/2024081901273_c.pdf","us_notice_code":"公告及通告 - [中期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2024-08-19 19:30","pubTimestamp":1724067000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17981539","market":"hk","labels":[],"media":"港交所","original_id":"N.HKGrSpNWQZg8","pdf_url":"https://static.tigerbbs.com/a626503a4f7a41dfa410dae3b5f3155f","pub_time":1714034400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告","symbol":"02137","title":"(1)建议采纳经审核合并财务报表；(2)重选退任董事；(3)续聘核数师；(4)发行及购回股份之一般授权；及(5)股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500851_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 在股东批准的情况下重选或委任董事]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2024-04-25 16:40","pubTimestamp":1714034400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17981540","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6CGabmVdib","pdf_url":"https://static.tigerbbs.com/abaa6008208f47f4b0e5e56ac3adb94d","pub_time":1714034280000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023年度报告","symbol":"02137","title":"2023年度报告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0425/2024042500753_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-04-25 16:38","pubTimestamp":1714034280,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17740475","market":"hk","labels":[],"media":"港交所","original_id":"N.HKHr1RmXF9fd","pdf_url":"https://static.tigerbbs.com/d3ec525cd72941d385edf815a35813c7","pub_time":1711105200000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2023年12月31日止年度之年度业绩公告","symbol":"02137","title":"截至2023年12月31日止年度之年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0322/2024032200932_c.pdf","us_notice_code":"公告及通告 - [末期业绩 / 暂停办理过户登记手续或更改暂停办理过户日期]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2024-03-22 19:00","pubTimestamp":1711105200,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"17591496","market":"hk","labels":[],"media":"港交所","original_id":"N.HKBiscC3hjxh","pdf_url":"https://static.tigerbbs.com/d814bc4c47224df5845bde4ed29319e7","pub_time":1707868740000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"有关BRII-179购买协议、技术转让补充协议、VBI-1901许可协议、REHOVOT资产购买协议及提供抵押之须予披露交易","symbol":"02137","title":"有关BRII-179购买协议、技术转让补充协议、VBI-1901许可协议、REHOVOT资产购买协议及提供抵押之须予披露交易","titleType":"须予披露的交易","type":"hkTrade","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2024/0214/2024021400024_c.pdf","us_notice_code":"公告及通告 - [须予披露的交易]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"交易相关","type_name_en":"Transaction Related","titleTypeEn":"","event_type":"important_notice","event_name":"须予披露的交易","pubTime":"2024-02-14 07:59","pubTimestamp":1707868740,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"16985360","market":"hk","labels":[],"media":"港交所","original_id":"N.HK6kBq2hK7cC","pdf_url":"https://static.tigerbbs.com/4d558272398147788f4cbb4d7caa2aaa","pub_time":1695285780000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"2023 中期报告","symbol":"02137","title":"2023 中期报告","titleType":"半年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2023/0921/2023092100520_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [中期/半年度报告]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Interim Report","event_type":"important_notice","event_name":"半年度报告","pubTime":"2023-09-21 16:43","pubTimestamp":1695285780,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.briibio.com","stockEarnings":[{"period":"1week","weight":-0.0333},{"period":"1month","weight":-0.1212},{"period":"3month","weight":-0.2487},{"period":"6month","weight":-0.1317},{"period":"1year","weight":0.4216},{"period":"ytd","weight":0.4796}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"腾盛博药生物科技有限公司是一家主要专注于开发感染性疾病及中枢神经系统疾病治疗方案的生物技术公司。该公司的HBV产品组合包括专有的治疗性疫苗BRII-179、the siRNA BRII-835 (elebsiran)，及中和抗体BRII-877 (tobevibart). 该公司拥有多种创新候选药物的产品线，专注于治疗传染病和中枢神经系统疾病。该公司的产品应用于传染病（如乙型肝炎病毒(HBV)、人类免疫缺陷病毒(HIV)、多重耐药(MDR)或广泛耐药性(XDR)革兰氏阴性菌感染）及其他疾病（如中枢神经系统(CNS)疾病）。该公司主要在中国国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.068599},{"month":2,"riseRate":0.5,"avgChangeRate":0.053469},{"month":3,"riseRate":0.25,"avgChangeRate":-0.171794},{"month":4,"riseRate":0.25,"avgChangeRate":-0.017909},{"month":5,"riseRate":0,"avgChangeRate":-0.064507},{"month":6,"riseRate":0.25,"avgChangeRate":-0.093488},{"month":7,"riseRate":1,"avgChangeRate":0.097158},{"month":8,"riseRate":0.2,"avgChangeRate":0.004254},{"month":9,"riseRate":0.6,"avgChangeRate":-0.00155},{"month":10,"riseRate":0.2,"avgChangeRate":-0.127852},{"month":11,"riseRate":0.6,"avgChangeRate":0.286305},{"month":12,"riseRate":0.2,"avgChangeRate":-0.149794}],"exchange":"SEHK","name":"腾盛博药-B","nameEN":"BRII-B"},"aProfile":null}}}